Masitinib for the treatment of mild to moderate Alzheimer's disease.
Folch J, Petrov D, Ettcheto M, Pedrós I, Abad S, Beas-Zarate C, Lazarowski A, Marin M, Olloquequi J, Auladell C, Camins A.
Folch J, et al. Among authors: petrov d.
Expert Rev Neurother. 2015 Jun;15(6):587-96. doi: 10.1586/14737175.2015.1045419. Epub 2015 May 11.
Expert Rev Neurother. 2015.
PMID: 25961655
Review.